Pyoderma gangrenosum;Le pyoderma gangrenosum

Presse Medicale

Volumn 31, Issue 31, 2002, Pages 1476-1481

  Mahé, Emmanuel ^a   Descamps, V ^a   Belaich S ^a   Cricks, B ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ARTICLE; BLOOD DISEASE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; ENTEROCOLITIS; INFLAMMATION; MONOCLONAL IMMUNOGLOBULINEMIA; MYELOID LEUKEMIA; PATHOPHYSIOLOGY; PUSTULE; PYODERMA GANGRENOSUM; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN INFILTRATE; SKIN ULCER; SUPERINFECTION;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEG ULCER; PYODERMA GANGRENOSUM; RISK FACTORS; SKIN;

EID: 0037190457     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Callen JP. Pyoderma gangrenosum. Lancet 1998; 351: 581-5.
2. Guilhou JJ, Guillot B, Meynadier J. Pyoderma gangrenosum. Quatorze observations personnelles et revue de la littérature. J Mal Vascul 1987; 12: 202-7.
3. Powel FC, Schoeter AI, Perry HO, Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985; 55: 173-86.
4. Powel FC, Su WPD, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 1996; 34: 395-409.
5. Moulin G, Augey F. Pyoderma gangrenosum. Presse Med 1990; 27: 1623-6.
6. Chevrant-Breton J, Logeais B, Pibouin M. Pyoderma gangrenosum (pyodermite phagédénique). Ann Dermatol Venereol 1989; 116: 577-89.
7. Blitz NM, Rudikoff D. Pyoderma gangrenosum. Mount Sinaï J Med 2001; 68: 287-97.
8. Levitt MD, Ritchie JK, Lennard-Jones JE, Phillips RKS. Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg 1991; 78: 676-8.
9. Castro-Durán J, Martín-Armada M, Jiménez-Alonso J. Pyoderma gangrenosum induced by acupuncture in a patient with ulcerative colitis. Arch Int Med 2000; 160: 2394.
10. Hughes AP, Jackson JM, Callen JP. Clinical features and treatment of peristomal Pyoderma gangrenosum. JAMA 2000; 284: 1546-8.
11. Sheldon DG, Sawchuk LL, Kozarek RA, Thirlby RC. Twenty cases of peristomal Pyoderma gangrenosum: diagnostic implications and management. Arch Surg 2000; 135: 564-8.
12. Tjandra JJ, Hughes LE. Parastomal Pyoderma gangrenosum in inflammatory bowel disease. Dis Colon Rectum 1994; 37: 938-42.
13. Krüger S, Piroth W, Takyi BA, Breuer C, Schwarz ER. Multiple aseptic pulmoanary nodules with central necrosis in association with Pyoderma gangrenosum. Chest 2001; 119: 977-8.
14. Bertram-Callens A, Machet L, Vaillant L, Camenen I, Lorette G. Localisations buccales et oculaires de Pyoderma gangrenosum au cours d'une maladie de Vaquez. Ann Dermatol Venereol 1991; 118: 611-14.
15. Yamagata M, Kumano K, Ueda M. Pyoderma gangrenosum associated with ulcerative colitis and subcutaneous and splenic abscesses. J Eur Acad Dermatol Venereol 1997; 9: 256-8.
16. Vignon-Pennamen MD, Zelinsky-Gurung A, Janssen F, Frija J, Wallach D. Pyoderma gangrenosum with pulmonary involvement. Arch Dermatol 1989; 125: 1239-42.
17. Setterfield JF, Shirlaw PJ, Challacombe SJ, Black MM. Pyoderma gangrenosum associated with severe orpharyngeal involvment and IgA paraproteinaemia. Br J Dermatol 2001; 144: 393-6.
18. Adachi Y, Kindzelskii AL, Cookingham G et al. Aberrant neutrophil trafficking and metabolic oscillations in severe Pyoderma gangrenosum. J Invest Dermatol 1998; 11: 259-68.
19. Shaya S, Kindzelskii AL, Minor J, Moore EC, Todd RF, Petty HR. Aberrant integrin (CR4; α(x)beta2; CD11c/CD18) oscillation on neutrophils in a mild form of pyoderma grangrenosum. J Invest Dermatol 1998; 111: 154-8.
20. Bulvik S, Jacobs P. Pyoderma gangrenosum in myelodysplasia responding to granulocyte macrophage-clony stimulating factor (GM-CSF). Br J Dermatol 1997; 136: 637-8.
21. Shpiro D, Gilat D, Fisher-Feld L, Shemer A, Gold I, Trau H. Pyoderma gangrenosum successfully treated with perilesional granulocyte-macrophage colony stimulating factor. Br J Dermatol 1998; 138: 368-9.
22. Smith JB, Shenefelt PD, Soto O, Valeriano J. Pyoderma gangrenosum in a patient with cryoglobulinemia and hepatitis C successfully treated with interferon alfa. J Am Acad Dermatol 1996, 34: 901-3.
23. Khandpur S, Mehta S, Reddy BS. Pyoderma gangrenosum in two siblings: a familial predisposition. Pediatr Dermatol 2001; 18: 308-12.
24. Shands JW, Flowers FP, Hill HM, Smith JO. Pyoderma gangrenosum in a kindred. J Am Acad Dermatol 1987; 16: 931-4.
25. Yeon HB, Lindor NM, Seidman JG, Seidman CE. Pyogenic arthritis, Pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet 2000; 66: 1443-8.
26. von den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 1997; 137: 1000-5.
27. Chow RKP, Ho VC. Treatment of Pyoderma gangrenosum. J Am Acad Dermatol 1996; 34: 1047-60.
28. Lugassy G, Ronnen M. Case report: severe pyoderma associated with familial Mediterranean fever-favorable response to colchicine in three patients. Am J Med Sci 1992; 304: 29-31.
29. Schuppe HC, Homey B, Assmann T, Martens R, Ruzicka T. Topical tacrolimus for Pyoderma gangrenosum. Lancet 1998; 351: 832.
30. Tan MH, Gordon M, Lebwohl O, George J, Lebwohl MG. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor a monoclonal antibody. Arch Dermatol 2001; 137: 930-3.
31. Kaddoura IL, Amm C. A rationale for adjuvant surgical intervention in Pyoderma gangrenosum. Ann Plast Surg 2001; 46: 23-8.
32. de Imus G, Golomb C, Wilkel C, Tsoukas M, Nowak M, Falanga V. Accelerated healing of Pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression. J Am Acad Dermatol 2001; 44: 61-6.
33. King KW, Murray A. Pyoderma gangrenosum in a patient with essential thrombocythemia. J Cutan Med Surg 2000; 4: 107-9.
34. Coors EA, von den Driesch P. Pyoderma gangrenosum in a patient with autoimmune haemolytic anaemia and complement deficiency. Br J Dermatol 2000; 143: 154-6.
35. Claudepierre P, Clerc D, Cariou D, Lavabre C, Venencie PY, Bisson M. SAPHO syndrome and Pyoderma gangrenosum: is it fortuitous? J Rheumatol 1996; 23: 400-2.
36. Clark HH, Cohen PR. Pyoderma gangrenosum in an HIV-infected patient. J Am Acad Dermatol 1995; 32: 912-4
37. Gangaram HB, Tan LP, Gan AT, Suraiya HH, Ganesapillai T. Pyoderma gangrenosum following treatment with isotretinoin. Br J Dermatol 1997; 136: 636-7.
38. Ross HJ, Moy LA, Kaplan R, Figlin RA. Bullous Pyoderma gangrenosum after granulocyte colony-stimulating factor treatment. Cancer 1991; 68: 441-3.
39. Park CW, Shin YS, Shin MJ, et al. Pyoderma gangrenosum and spinal epidural abscee after subcutaneous administration of recombinant human erythropoietin. Nephrol Dial Transplant 1997; 12: 1506-8.
40. Montoto S, Bosch F, Estrach T, Blade J, Nomdedeu B, Nontserrat F. Pyoderma gangrenosum triggered by α2b-interferon in patient with chronic granulocytic leukemia. Leuk Lymphoma 1998; 30: 199-202.
41. Carp JM, Onuma E, Das K, Gottlieb AB. Intravenous cyclosporine therapy in the treatment of Pyoderma gangrenosum secondary to Crohn's disease. Cutis 1997; 60: 135-8.
42. Abu-Elmagd K, Van Thiel DH, Jegasothy BV, Jacobs JC, Carroll P, Rodriquez-Rilo H, et al. Resolution of severe Pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). Ann Intern Med 1993; 119: 595-8.
43. Hohenleutner U, Mohr VD, Michel S, Landthaler M. Mycophenolate mofetil and cyclosporin treatment for recalcitrant Pyoderma gangrenosum. Lancet 1997; 350: 1748.
44. Gupta AK, Shear NH, Sauder DN. Efficacy of human intravenous immune globulin in Pyoderma gangrenosum. J Am Acad Dermatol 1995; 32: 140-2.
45. Li LF. Treatment of Pyoderma gangrenosum with oral Trypterygium wilfordii multiglycoside. J Dermatol 2000; 27: 478-81.